Pfizer Inc.

PFE

$39.58

+7.0% (1 year change)

Avg closing price

Price range

Market Cap

$219 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$30.35 - $42.20

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

22.74x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.52 (3.87%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $219 Billion
Enterprise Value $246 Billion
Dividend Yield $1.52 (3.87%)
1 Year Return +10.9%
52-Week High $42.20
52-Week Low $30.35
Beta 0.55
Outstanding Shares 5.58 Billion
Avg 30 Day Volume 32.4 Million

Valuation

P/E Ratio 22.74
PEG -31.83
Earnings per Share $1.71
Price to Sales Ratio 4.95
Price to Book Ratio 3.6
Revenue to Enterprise Value 5.06
EBIT to Enterprise Value 17.99
Total Debt to Enterprise Value 0.16
Debt to Equity 0.63

Profitability

Revenue $48.6 Billion
Gross Profit $38.9 Billion
EBIT $13.7 Billion
Net Income $8.68 Billion
Profit Margin 17.84%
Quarterly Earnings Growth (YoY) -71.4%
Return on Equity 13.73%
Return on Assets 5.63%
Return on Invested Capital 10.67%

News

FICCI Prez backs indemnity for vaccine makers

FICCI Prez backs indemnity for vaccine makers

The government should consider requests of global drugmakers Pfizer and Moderna for indemnity protection to bring their Covid-19 vaccines into the country as mass vaccination is key in the fight ag...

Economic Times India Economic Times India, 1 day ago
Pfizer vaccine highly effective against 2 variants, studies say; US backs waiving intellectual property rules on vaccines: COVID-19 updates

Pfizer vaccine highly effective against 2 variants, studies say; US backs waiving intellectual property rules on vaccines: COVID-19 updates

Hospitalizations and deaths should decline sharply if the vaccination program remains strong and mitigation efforts are followed. Latest COVID news.

USA Today USA Today, 2 days ago
Who Is — And Will Be — Making Money From COVID-19 Vaccines?

Who Is — And Will Be — Making Money From COVID-19 Vaccines?

Schroders' Expert John Bowler Analyzes The Pharmaceutical Groups Involved In COVID-19 Drug Development, Emphasizing That Their Efforts Will Be Rewarded In The Future, Despite Current Low Benefits. ...

Benzinga Benzinga, 5 days ago